Currently out of the existing stock ratings of Jonathan Lee, 42 are a BUY (95.45%), 2 are a HOLD (4.55%).

Jonathan Lee

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Lee, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 23.69% that have a potential upside of 16.78% achieved within 74 days. Previously, Jonathan Lee worked at BMO, MORGAN STANLEY.

Jonathan Lee’s has documented 81 price targets and ratings displayed on 7 stocks. The coverage is on Technology, Healthcare sectors.

Most recent stock forecast was given on ACN, Accenture plc at 22-Jun-2026.

Wall Street Analyst Jonathan Lee

Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/29/2025. The price target of $86 was fulfilled within 120 days with a profit of $36.71 (74.48%) receiving and performance score of 6.21.

Average potential price target upside

of $44.39 (26.69%) on EPAM (EPAM SYSTEMS).
of $22.46 (45.26%) on PTCT (PTC THERAPEUTICS).

ACN Accenture plc CTSH Cognizant Technology Solutions Corp DAVA Endava Ltd EPAM EPAM Systems GLOB Globant SA KD Kyndryl Holdings PTCT PTC Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Bryan Bergin (TD COWEN)